NCT05923112View on ClinicalTrials.gov

BESPONSA Injection 1 mg Special Investigation

CompletedOBSERVATIONAL

Enrollment

421

Participants

Timeline

Start Date

July 2, 2018

Primary Completion Date

September 6, 2024

Study Completion Date

September 6, 2024

Conditions

Acute Lymphocytic Leukemia

Trial Locations (1)

Unknown

Pfizer, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY